Lilly Asia Ventures has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It is a venture capital firm based in Hong Kong, HK, founded in 2008. Its most recent investment on record is NeuShen Therapeutics's $80M Series B+ round in September 2026, alongside TruMed Investment, Shanghai Guotou Pioneer, Matrix Partners China and 2 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with B Capital, Matrix Partners China and TruMed Investment.

About Lilly Asia Ventures

Fund returns

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Funds raised

Venture funds Lilly Asia Ventures raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

What Lilly Asia Ventures invests in

• Health and bio · 2 · 100%

How Lilly Asia Ventures invests

Share is of the 2 rounds on Recent Funding that name Lilly Asia Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Lilly Asia Ventures portfolio companies

• NNeuShen Therapeutics$80MSeries B+ · Sep 2026
• SSynthekine$108MSeries B+ · Jun 2021

Most frequent co-investors

• BB Capital1 shared round · last Sep 7, 2026
• MMatrix Partners China1 shared round · last Sep 7, 2026
• TTruMed Investment1 shared round · last Sep 7, 2026
• SShanghai Guotou Pioneer1 shared round · last Sep 7, 2026
• LLegend Capital1 shared round · last Sep 7, 2026
• JJanus Henderson Investors1 shared round · last Jun 10, 2021
• EEmerson Collective1 shared round · last Jun 10, 2021
• RRA Capital Management1 shared round · last Jun 10, 2021
• SSamsara Biocapital1 shared round · last Jun 10, 2021
• TThe Column Group1 shared round · last Jun 10, 2021
• TTCG Crossover1 shared round · last Jun 10, 2021
• DDeerfield1 shared round · last Jun 10, 2021

Similar investors

• CCalm/Storm VC2 companies · 2 deals in 12 mo
• GGoHub Ventures2 companies · 2 deals in 12 mo
• GGolden Ventures2 companies · 2 deals in 12 mo
• HHuatai Zijin Investment2 companies · 2 deals in 12 mo
• IIIMA Ventures2 companies · 2 deals in 12 mo
• SSound Bioventures2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Lilly Asia Ventures, which is a subset of its real portfolio. API: /api/v1/investors/lilly-asia-ventures (get a free API key). More: the most active VC firms and new venture capital funds.